488 related articles for article (PubMed ID: 31177016)
1. DL-3-n-butylphthalide attenuates lipopolysaccharide-induced acute lung injury via SIRT1-dependent and -independent regulation of Nrf2.
Gong Q; Xue Y; Li X; Song L; Zhu L
Int Immunopharmacol; 2019 Sep; 74():105658. PubMed ID: 31177016
[TBL] [Abstract][Full Text] [Related]
2. Preventive and therapeutic effects of Danhong injection on lipopolysaccharide induced acute lung injury in mice.
Wan LM; Tan L; Wang ZR; Liu SX; Wang YL; Liang SY; Zhong JB; Lin HS
J Ethnopharmacol; 2013 Aug; 149(1):352-9. PubMed ID: 23850708
[TBL] [Abstract][Full Text] [Related]
3. Suppression of NLRP3 and NF-κB signaling pathways by α-Cyperone via activating SIRT1 contributes to attenuation of LPS-induced acute lung injury in mice.
Liu X; Jin X; Yu D; Liu G
Int Immunopharmacol; 2019 Nov; 76():105886. PubMed ID: 31520990
[TBL] [Abstract][Full Text] [Related]
4. Usnic acid protects LPS-induced acute lung injury in mice through attenuating inflammatory responses and oxidative stress.
Su ZQ; Mo ZZ; Liao JB; Feng XX; Liang YZ; Zhang X; Liu YH; Chen XY; Chen ZW; Su ZR; Lai XP
Int Immunopharmacol; 2014 Oct; 22(2):371-8. PubMed ID: 25068825
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of pogostone against LPS-induced acute lung injury in mice via regulation of Keap1-Nrf2/NF-κB signaling pathways.
Sun CY; Xu LQ; Zhang ZB; Chen CH; Huang YZ; Su ZQ; Guo HZ; Chen XY; Zhang X; Liu YH; Chen JN; Lai XP; Li YC; Su ZR
Int Immunopharmacol; 2016 Mar; 32():55-61. PubMed ID: 26800098
[TBL] [Abstract][Full Text] [Related]
6. Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway.
Huang Y; Huang L; Zhu G; Pei Z; Zhang W
J Cell Physiol; 2019 May; 234(5):6023-6032. PubMed ID: 30584668
[TBL] [Abstract][Full Text] [Related]
7. The protective effect of Trillin LPS-induced acute lung injury by the regulations of inflammation and oxidative state.
Jiang W; Luo F; Lu Q; Liu J; Li P; Wang X; Fu Y; Hao K; Yan T; Ding X
Chem Biol Interact; 2016 Jan; 243():127-34. PubMed ID: 26363199
[TBL] [Abstract][Full Text] [Related]
8. Aucubin protects against lipopolysaccharide-induced acute pulmonary injury through regulating Nrf2 and AMPK pathways.
Qiu YL; Cheng XN; Bai F; Fang LY; Hu HZ; Sun DQ
Biomed Pharmacother; 2018 Oct; 106():192-199. PubMed ID: 29958143
[TBL] [Abstract][Full Text] [Related]
9. Febuxostat protects rats against lipopolysaccharide-induced lung inflammation in a dose-dependent manner.
Fahmi AN; Shehatou GS; Shebl AM; Salem HA
Naunyn Schmiedebergs Arch Pharmacol; 2016 Mar; 389(3):269-78. PubMed ID: 26713331
[TBL] [Abstract][Full Text] [Related]
10. hucMSC Conditioned Medium Ameliorate Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Oxidative Stress and Inflammation via Nrf2/NF-
Tang Y; Ding F; Wu C; Liu B
Anal Cell Pathol (Amst); 2021; 2021():6653681. PubMed ID: 34426780
[TBL] [Abstract][Full Text] [Related]
11. Dl-3-n-Butylphthalide improves lipopolysaccharide-induced depressive-like behavior in rats: involvement of Nrf2 and NF-κB pathways.
Yang M; Dang R; Xu P; Guo Y; Han W; Liao D; Jiang P
Psychopharmacology (Berl); 2018 Sep; 235(9):2573-2585. PubMed ID: 29943092
[TBL] [Abstract][Full Text] [Related]
12. Bardoxolone treatment alleviates lipopolysaccharide (LPS)-induced acute lung injury through suppressing inflammation and oxidative stress regulated by Nrf2 signaling.
Pei X; Zhang XJ; Chen HM
Biochem Biophys Res Commun; 2019 Aug; 516(1):270-277. PubMed ID: 31248593
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury.
Zhang Y; Liang D; Dong L; Ge X; Xu F; Chen W; Dai Y; Li H; Zou P; Yang S; Liang G
Respir Res; 2015 Mar; 16(1):43. PubMed ID: 25889862
[TBL] [Abstract][Full Text] [Related]
14. Vitexin attenuates lipopolysaccharide-induced acute lung injury by controlling the Nrf2 pathway.
Lu Y; Yu T; Liu J; Gu L
PLoS One; 2018; 13(4):e0196405. PubMed ID: 29694408
[TBL] [Abstract][Full Text] [Related]
15. Baicalin ameliorates lipopolysaccharide-induced acute lung injury in mice by suppressing oxidative stress and inflammation via the activation of the Nrf2-mediated HO-1 signaling pathway.
Meng X; Hu L; Li W
Naunyn Schmiedebergs Arch Pharmacol; 2019 Nov; 392(11):1421-1433. PubMed ID: 31273392
[TBL] [Abstract][Full Text] [Related]
16. Orientin relieves lipopolysaccharide-induced acute lung injury in mice: The involvement of its anti-inflammatory and anti-oxidant properties.
Xiao Q; Cui Y; Zhao Y; Liu L; Wang H; Yang L
Int Immunopharmacol; 2021 Jan; 90():107189. PubMed ID: 33214095
[TBL] [Abstract][Full Text] [Related]
17. PIM1 inhibitor SMI-4a attenuated lipopolysaccharide-induced acute lung injury through suppressing macrophage inflammatory responses via modulating p65 phosphorylation.
Wang J; Cao Y; Liu Y; Zhang X; Ji F; Li J; Zou Y
Int Immunopharmacol; 2019 Aug; 73():568-574. PubMed ID: 31203114
[TBL] [Abstract][Full Text] [Related]
18. Sulforaphane exerts anti-inflammatory effects against lipopolysaccharide-induced acute lung injury in mice through the Nrf2/ARE pathway.
Qi T; Xu F; Yan X; Li S; Li H
Int J Mol Med; 2016 Jan; 37(1):182-8. PubMed ID: 26531002
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone releasing peptide-2, a ghrelin agonist, attenuates lipopolysaccharide-induced acute lung injury in rats.
Li G; Li J; Zhou Q; Song X; Liang H; Huang L
Tohoku J Exp Med; 2010 Sep; 222(1):7-13. PubMed ID: 20805679
[TBL] [Abstract][Full Text] [Related]
20. Isovitexin Exerts Anti-Inflammatory and Anti-Oxidant Activities on Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting MAPK and NF-κB and Activating HO-1/Nrf2 Pathways.
Lv H; Yu Z; Zheng Y; Wang L; Qin X; Cheng G; Ci X
Int J Biol Sci; 2016; 12(1):72-86. PubMed ID: 26722219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
